Insider Selling: MiMedx Group, Inc. (NASDAQ:MDXG) CAO Sells $430,762.44 in Stock

MiMedx Group, Inc. (NASDAQ:MDXG) CAO William Frank Iv Hulse sold 54,596 shares of MiMedx Group stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $7.89, for a total transaction of $430,762.44. Following the completion of the sale, the chief accounting officer now directly owns 440,178 shares in the company, valued at $3,473,004.42. This represents a 11.03 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

William Frank Iv Hulse also recently made the following trade(s):

• On Monday, March 10th, William Frank Iv Hulse sold 81,446 shares of MiMedx Group stock. The shares were sold at an average price of $7.80, for a total transaction of $635,278.80.

MiMedx Group Trading Up 0.4 %

Shares of MDXG stock opened at $7.92 on Monday. The stock’s fifty day moving average is $8.45 and its two-hundred day moving average is $7.82. The company has a debt-to-equity ratio of 0.10, a quick ratio of 3.53 and a current ratio of 4.10. The firm has a market capitalization of $1.17 billion, a P/E ratio of 14.40 and a beta of 1.97. MiMedx Group, Inc. has a fifty-two week low of $5.47 and a fifty-two week high of $10.14.

MiMedx Group (NASDAQ:MDXG) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.07 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.07. The company had revenue of $92.91 million for the quarter, compared to analyst estimates of $89.42 million. MiMedx Group had a return on equity of 26.21% and a net margin of 23.86%. Research analysts expect that MiMedx Group, Inc. will post 0.3 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. IMG Wealth Management Inc. purchased a new position in shares of MiMedx Group during the 4th quarter worth $28,000. Virtus Fund Advisers LLC purchased a new position in shares of MiMedx Group during the 4th quarter worth $35,000. Van ECK Associates Corp purchased a new position in shares of MiMedx Group during the 4th quarter worth $40,000. Point72 DIFC Ltd raised its holdings in shares of MiMedx Group by 127.6% during the 3rd quarter. Point72 DIFC Ltd now owns 7,626 shares of the company’s stock worth $45,000 after acquiring an additional 4,275 shares during the period. Finally, Tower Research Capital LLC TRC raised its holdings in shares of MiMedx Group by 77.4% during the 4th quarter. Tower Research Capital LLC TRC now owns 6,501 shares of the company’s stock worth $63,000 after acquiring an additional 2,837 shares during the period. Hedge funds and other institutional investors own 79.15% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Cantor Fitzgerald reissued an “overweight” rating and issued a $13.00 price target on shares of MiMedx Group in a research note on Thursday, February 27th.

MiMedx Group Company Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.